Furthermore, the role of curcumin in regulating p53 stability in MDA-MB-231 triple-negative breast cancer (TNBC) cells was assessed, where 20 μM curcumin treatment increased the half-life of the p53 protein. The gene discussed is TP53; the disease is triple-negative breast carcinoma.